Company: REVB
Filing Date: 2025-05-23
Form Type: S-1/A
Source: 0001213900-25-047104
Chunk: 174

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-23
Form: S-1/A
Chunk 174
---
 However, exculpation does not apply to any director if the director has breached such director’s duty of loyalty, acted in bad faith, knowingly or intentionally violated the law, authorized illegal dividends, redemptions or repurchases or derived an improper benefit from his or her actions as a director. The limitation of liability provision in the Charter may discourage stockholders from bringing a lawsuit against directors for breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against directors and officers, even though such an action, if successful, might otherwise benefit us and our stockholders. In addition, your investment may be adversely affected to the extent we pay the costs of settlement and damage awards against directors and officers pursuant to these indemnification provisions. There is currently no pending material litigation or proceeding involving any of our directors, officers or employees for which indemnification is sought. Listing The Common Stock and Public Warrants of Revelation are listed on the Nasdaq Capital Market under the symbol “REVB” and “REVBW”. 110 SECURITIES ACT RESTRICTIONS ON RESALE OF COMMON STOCK Rule 144 Pursuant to Rule 144 under the Securities Act (“Rule 144”), a person who has beneficially owned restricted Shares of Common Stock or Warrants of Revelation for at least six months would be entitled to sell their securities provided that (i) such person is not deemed to have been an affiliate of Revelation at the time of, or at any time during the three months preceding, a sale and (ii) Revelation is subject to the Exchange Act periodic reporting requirements for at least three months before the sale and has filed all required reports under Section 13 or 15(d) of the Exchange Act during the 12 months (or such shorter period as it was required to file reports) preceding the sale. Persons who have beneficially owned restricted Shares of Common Stock or Warrants of Revelation for at least six months but who are affiliates of Revelation at the time of, or at any time during the three months preceding, a sale would be subject to additional restrictions, by which such person would be entitled to sell within any three-month period only a number of securities that does not exceed the greater of:

| ● | 1% of the total number of shares of Common Stock then outstanding; 
 or                                                                 |

| ● | the average weekly reported trading volume of Common Stock                                            
 during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale. |

Sales by affiliates of Revelation under